HEXADROL Trademark

Trademark Overview

On Tuesday, November 2, 2021, a trademark application was filed for HEXADROL with the United States Patent and Trademark Office. The USPTO has given the HEXADROL trademark a serial number of 97104724. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 23, 2024. This trademark is owned by Pharma Trademarks Inc.. The HEXADROL trademark is filed in the Pharmaceutical Products category with the following description:

Synthetic adrenal steroid preparation to be used in the treatment of inflammatory and allergic conditions
hexadrol

General Information

Serial Number97104724
Word MarkHEXADROL
Filing DateTuesday, November 2, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements

Goods and ServicesSynthetic adrenal steroid preparation to be used in the treatment of inflammatory and allergic conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePharma Trademarks Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCheyenne, WY 82001
Party NamePharma Trademarks Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCheyenne, WY 82001

Trademark Events

Event DateEvent Description
Friday, November 5, 2021NEW APPLICATION ENTERED
Friday, November 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 11, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, August 11, 2022ASSIGNED TO EXAMINER
Thursday, August 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 18, 2022NON-FINAL ACTION WRITTEN
Thursday, August 18, 2022NON-FINAL ACTION E-MAILED
Thursday, August 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 18, 2023ASSIGNED TO LIE
Thursday, May 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 25, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 21, 2024SOU EXTENSION 1 GRANTED
Wednesday, February 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 21, 2024SOU EXTENSION 1 FILED
Thursday, February 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 23, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

hexadrol inflammatory allergic conditions treatment used adrenal steroid preparation synthetic